Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Pentixapharm Holding AG: A reportable insider transaction was published on 4th October 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 4th October 2024,
The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH 
. The transaction toke place on 3rd October 2024. The order was executed at the trading place Frankfurter Wertpapierbörse. . The aggregated volume was 33.643.068,00 EUR, based on an average price of 5,10 EUR. The nature of the Investment was not specified.
Eckert & Ziegler SE: A reportable insider transaction was published on 26th March 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 26th March 2024,
The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 25th March 2024. . The aggregated volume was 247.699,20 EUR, based on an average price of 36,86 EUR. The nature of the Investment was Buy.
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 30th August 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 30th August 2023,
The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 28th August 2023. . The aggregated volume was 1.526.400,00 EUR, based on an average price of 31,80 EUR. The nature of the Investment was Buy.
Eckert & Ziegler SE: A reportable insider transaction was published on 30th August 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 30th August 2023,
The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 28th August 2023. . The aggregated volume was 1.526.400,00 EUR, based on an average price of 31,80 EUR. The nature of the Investment was Buy.
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 21st December 2022. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 21st December 2022,
The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 19th December 2022. . The aggregated volume was 1.432.800,00 EUR, based on an average price of 47,76 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.